Feasibility and oncologic outcomes of minimally invasive surgery after induction chemoimmunotherapy for non–small cell lung cancerCentral MessagePerspective

Objective: We evaluated the feasibility and long-term outcomes of minimally invasive surgery (MIS) after neoadjuvant immunotherapy in patients with resectable non–small cell lung cancer (NSCLC). Methods: Patients with stage IB-IIIB NSCLC who underwent induction immunotherapy followed by surgery (201...

Descripció completa

Dades bibliogràfiques

Autors principals:	Giovanni M. Comacchio, MD, Marisa Sewell, MD, Kay See Tan, PhD, Nicolas Toumbacaris, MD, Matthew J. Bott, MD, Prasad S. Adusumilli, MD, Alexis Chidi, MD, PhD, Katherine Gray, MD, James Huang, MD, James M. Isbell, MD, Bernard J. Park, MD, Gaetano Rocco, MD, Valerie W. Rusch, MD, Smita Sihag, MD, David R. Jones, MD, Daniela Molena, MD
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-04-01
Col·lecció:	JTCVS Open
Matèries:	minimally invasive surgery induction therapy immunotherapy non–small cell lung cancer
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S266627362600046X
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!